Medicare Program; Manufacturer Submission of Manufacturer's Average Sales Price (ASP) Data for Medicare Part B Drugs and Biologicals
medicare · Centers for Medicare and Medicaid Services · Rule · Published 2004-09-16 · Effective 2004-09-16 · 69 FR 55763
Document
Document number
04-20823
Federal Register citation
69 FR 55763
CFR reference
42 CFR 414
Type
Rule
Action
Final rule.
Category
medicare
Sub-agency
Centers for Medicare and Medicaid Services
Publication date
2004-09-16
Effective date
2004-09-16
HHS docket
CMS-1380-F
Abstract
On April 6, 2004, we published an interim final rule in the Federal Register implementing the provisions of the Medicare Prescription Drug, Improvement, and Modernization Act of 2003 (MMA) related to the calculation and submission of manufacturer's average sales price (ASP) data on certain Medicare Part B drugs and biologicals by manufacturers. This final rule responds to the public comments received on the interim final rule concerning the methodology for estimating price concessions associated with manufacturers' ASP reporting requirements. Other issues and comments relating to the interim final rule will be addressed at a future time.